-
Sector Analysis
NewCzech Republic Statutory and Private Employee Benefits, 2024 Update
Czech Republic Statutory and Private Employee Benefits Report Overview The Czech Republic has a well-developed social security system. Employers, employees, and self-employed people contribute to the social security schemes. The country’s social security system is built on three pillars: compulsory social insurance, state social support system, and social assistance. Compulsory social insurance covers pension insurance, health insurance, and the national employment policy system. The non-contributory state social support system supports families with dependent children. The final pillar, tax-financed social assistance,...
-
Product Insights
Likelihood of Approval Analysis for Rabies
Overview How likely is it that the drugs in Rabies will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Rabies Overview Rabies is a deadly virus spread to people from the saliva...
-
Product Insights
Likelihood of Approval Analysis for Psoriatic Arthritis
Overview How likely is it that the drugs in Psoriatic Arthritis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Psoriatic Arthritis Overview Psoriatic arthritis is a form of arthritis that affects...
-
Product Insights
Likelihood of Approval Analysis for Sickle Cell Disease With Vaso-Occlusive Crisis
Overview How likely is it that the drugs in Sickle Cell Disease With Vaso-Occlusive Crisis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Sickle Cell Disease With Vaso-Occlusive Crisis Overview Vaso-occlusive...
-
Product Insights
Likelihood of Approval Analysis for Salmonella typhi Infections
Overview How likely is it that the drugs in Salmonella typhi Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Salmonella typhi Infections Overview Salmonella Typhi (S. Typhi) are bacteria that...
-
Product Insights
Likelihood of Approval Analysis for Malaria
Overview How likely is it that the drugs in Malaria will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Malaria Overview Malaria is a life-threatening blood disease caused by a parasite (Plasmodium)...
-
Product Insights
Likelihood of Approval Analysis for Uveal Melanoma
Overview How likely is it that the drugs in Uveal Melanoma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Uveal Melanoma Overview Uveal melanoma, the most common intraocular tumor, is a...
-
Product Insights
Likelihood of Approval Analysis for Togaviridae Infections
Overview How likely is it that the drugs in Togaviridae Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Togaviridae Infections Overview The Togaviridae is a family of enveloped, single-stranded, plus-strand...
-
Product Insights
Likelihood of Approval Analysis for Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma)
Overview How likely is it that the drugs in Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Overview Hodgkin lymphoma is...
-
Product Insights
Likelihood of Approval Analysis for Neisseria Infections
Overview How likely is it that the drugs in Neisseria Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Neisseria Infections Overview Meningococcal disease refers to any illness caused by bacteria...